$IRD
Opus Genetics, Inc. Common Stock
XNAS•Health Care•Pharmaceutical Preparations
$3.82
▼-5.68%-$0.230
Subscriptions are live. Early access $24.99/mo, or start with 5 free premium days.
Plans & pricingDonateOpus Genetics, Inc. Common Stock
XNAS•Health Care•Pharmaceutical Preparations
Why is IRD down today? It is at $3.82 (-5.68%), and our scanner flagged it 121 times on unusual volume this month. See the catalyst behind the move, real-time alerts the moment IRD spikes, and full due diligence on IRD — key stats, earnings, dilution and insider activity. Free.
Our scanner flagged $IRD 121 times in the last 30 days. Create a free account to track $IRD, build a watchlist, and get instant unusual-volume alerts, with a full day of premium now and 5 more when you verify your email, no card needed.
No card · 5 premium days · join 800+ traders
The top plays and unusual-volume catches our scanner flags, emailed to you. No account needed.
No spam. Unsubscribe anytime. Not investment advice.
Here is the latest on IRD from our scanner (live price and day move above). We have not detected an unusual-volume catalyst for IRD today, so it is trading in line with its recent range. The moment our scanner flags unusual activity, the reason will appear here.
Likely catalystClinical / FDA update, from the latest SEC filing. Read it →Across every filing on file, supply equal to 376.9% of the tradeable float is in play - 12.4% has already been sold, and 364.4% more can still be issued.
Shelf sizes are dollars, so shares are estimated at today's price.
Recent share offering + active shelf on file — the company raised capital and can raise more
2,678,570 new shares · Priced at $4.48/share
Sources: float & market cap via Polygon · short interest via FINRA · borrow & shortability via Alpaca · SSR from Reg SHO 201 · filings & dilution via SEC EDGAR · analysts via Nasdaq.
Auto-generated from public data for research and education. Not investment advice.
| Insider | Action | Shares | % of position | Owns after | Value | Date |
|---|---|---|---|---|---|---|
Foundation Fighting Blindness Retinal Degeneration Fund Director | Sold (automatic/other) | -556K 0.7% of company | sold 15% | 3.24M | $2.8M at $4.96 | Sep 30, 26 |
Magrath George Officer | Sold (automatic/other) | -76K 0.09% of company | sold 3.6% | 2.05M | $451K at $5.97 | Sep 9, 26 |
Magrath George Officer | Other | 392K 0.5% of company | added 23% | 2.12M | $451K at $1.15 | Sep 9, 26 |
Gallagher Cam Director | Other | 784K 0.9% of company | added 39% | 2.80M | $902K at $1.15 | Sep 8, 26 |
Gagnon Robert E. Officer | Sold (automatic/other) | -28K 0.03% of company | sold 4.8% | 556K | $127K at $4.54 | Sep 3, 26 |
Gagnon Robert E. Officer | Sold (automatic/other) | -8K | sold 1.3% | 584K | $23K at $2.95 | Jul 23, 26 |
Magrath George Officer | Sold (automatic/other) | -9K 0.01% of company | sold 0.5% | 1.73M | $28K at $2.95 | Jul 23, 26 |
Schachle Joseph K Officer | Sold (automatic/other) | -5K | sold 1.6% | 291K | $14K at $2.94 | Jul 23, 26 |
Yerxa Benjamin R Officer | Sold (automatic/other) | -7K | sold 1.0% | 704K | $22K at $2.97 | Jul 23, 26 |
Foundation Fighting Blindness Retinal Degeneration Fund Director | Sold (automatic/other) | -1.70M 2.0% of company | sold 31% | 3.79M | $7.4M at $4.35 | May 18, 26 |
Gagnon Robert E. Officer | Sold (automatic/other) | -8K | sold 1.3% | 592K | $41K at $5.18 | Apr 23, 26 |
Jayagopal Ashwath Officer | Sold (automatic/other) | -8K | sold 1.5% | 509K | $39K at $5.19 | Apr 23, 26 |
Recent Form-4 filings via Nasdaq. Open-market buys are the signal worth watching. Grants and automatic (10b5-1) sells are routine. “% of position” is the share of that insider’s own holding the trade moved. Not investment advice.
Blend of news sentiment, today’s move, and community votes. Not investment advice.
News, unusual-volume alerts, AI-trader trades and community chatter - the whole story, newest first.
The tickers our scanner is lighting up most over the last 48 hours.
Comparable names in pharmaceutical preparations, closest in size first.
Here is the latest on IRD from our scanner (live price and day move above). We have not detected an unusual-volume catalyst for IRD today, so it is trading in line with its recent range. The moment our scanner flags unusual activity, the reason will appear here.
IRD last traded at $3.82, down 5.68% on the day. The price and chart above update live during market hours (4 AM to 8 PM ET).
Opus Genetics, Inc. Common Stock (IRD) is next expected to report earnings on Wednesday, November 11, 2026, about 25 days away. Earnings reports often cause large overnight gaps, so many traders manage risk around the date. The date can shift until the company officially confirms it.
The IRD Live Alerts panel on this page streams real-time unusual volume (RVOL), momentum, halt and 200-EMA alerts from our scanner the moment they fire. Our scanner has flagged IRD 121 times in the last 30 days.
IRD (Opus Genetics, Inc. Common Stock) trades on XNAS, with a market cap of about $319M in the PHARMACEUTICAL PREPARATIONS sector.
That depends on your strategy and risk. Day traders look for volume, volatility and a clear trend. Use the live chart, RVOL alerts and 200-EMA context on this page to judge IRD for yourself. This is not investment advice.
Live data from TheDesperateTrader scanner. Not investment advice.
$IRD discussion
Sign in to ask a question or join the discussion.